共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
The effect of olfactory stimulation with jasmin and its component chemicals on pentobarbital sleep time was investigated using mice. In the present study we sought to determine which component of jasmin influences pentobarbital sleep time via olfactory stimulation. Sleep time was defined as the time elapsed between intraperitoneal pentobarbital administration and the first time that the animal was able to spontaneously right itself. Sleep time was significantly decreased by olfactory stimulation with jasmin, and also by one of the fractions obtained by fractional distillation at 150 degrees C and 0.1 mmHg. The fraction which influenced the sleep time was found to consist of benzyl benzoate, isophytol, geranyl linalool, phytol and phytyl acetate, which were identified using gas chromatography with mass and infrared spectrometry. In experiments using authentic samples of these components, phytol significantly shortened the pentobarbital sleep time, while the others had no effect. We conclude that phytol is the component of jasmin which reduces the duration of pentobarbital-induced sleep. 相似文献
11.
12.
13.
14.
15.
16.
17.
W Klinger T Kusch A Neugebauer F K Splinter H Ankermann 《Acta biologica et medica Germanica》1968,21(3):257-269
18.
19.
The effect of two different loading doses of L-tryptophan (0.5 and 1.0 g/Kg b.w.) on excretion of tryptophan metabolites and the relation to the enzyme activities were studied in rats, mice and guinea pigs. In rats there is no ratio between the dosage used and the levels of the metabolites excreted. Doubling the amount of tryptophan administered, a 5-fold increase in the elimination of the metabolites along the kynurenine pathway is obtained. The 1.0 g/Kg load provides a more complete pattern of the metabolites than with the 0.5 g/Kg b.w. load. Kynurenic acid, kynurenine and xanthurenic acid are the chief metabolites excreted. In mice, the urinary excretion of the metabolites is very low with both loads. In guinea pigs, xanthurenic acid is excreted in the highest amount and kynurenic acid and kynurenine also constitute the large fractions with both loadings. The load of 0.5 g/Kg b.w. is preferable to that of 1.0 g/Kg b.w. for not causing B6-deficiency. Liver tryptophan pyrrolase exists in two forms in rats, while in mice and in guinea pigs it is present only as holoenzyme. This enzyme is more active in rats than in the other two species of animals. Kynureninase activity is lower in guinea pigs, but it apparently correlated to the low levels of excretion of the metabolites following this step. Kynurenine aminotransferase is very active in rats and in mice, while it is apparently depressed in guinea pigs, in contrast with the high excretion of xanthurenic and kynurenic acids, that puts in evidence a B6-deficiency. The excretion of tryptophan metabolites and enzyme activities are better correlated in rats. 相似文献
20.
B Jastrzebska I Derdowska W Kowalczyk A Machova J Slaninová B Lammek 《The journal of peptide research》2003,62(2):70-77
In this study we describe the synthesis and some pharmacological properties of seven new analogues of arginine vasopressin (AVP) substituted in position 2 or 3 with 1-aminocyclohexane-1-carboxylic acid (Acc). All peptides were tested for the pressor, antidiuretic and uterotonic in vitro activities. The Acc3 modifications of AVP, dAVP, [d-Arg8]VP and [Cpa1]AVP have been found to be deleterious for interaction with all three neurohypophyseal hormone receptors, as judged from the several orders of magnitude decreased biological activities, whereas Acc2 substitution selectively altered the interaction with the receptors. Two of the new analogues, [Acc2]AVP and [Acc2, d-Arg8]AVP, are potent antidiuretic agonists. [Acc2]AVP exhibits moderate pressor agonistic activity and weak antiuterotonic properties. [Acc2, d-Arg8]AVP has been found to be a weak antagonist in the pressor and uterotonic tests. Another analogue - [Cpa1, Acc3]AVP - turned out to be a highly selective V2 agonist. This is an unexpected effect, as its parent peptide, [Cpa1]AVP is a very potent V1a receptor antagonist. This is the first Cpa1 modification to have resulted in V2 agonism enhancement. Besides providing useful information about structure-activity relationships, our results could open up new possibilities in the design of highly potent and selective V2 agonists. 相似文献